Search

Eva Surmacz

from Phila, PA
Age ~67
Get Report
Also known as:
Ewa Surmacz, Ewa Z
Phone and address:
706 S 2Nd St UNIT 8, Philadelphia, PA 19147
Connected to:
Elizabeth M Surmacz, 42Alan V Surman, 72Darren E Surman, 46Janet S Surman, 65Nicole L Surman, 35Robert F Surmani, 68Lynn C Surmann, 66Joseph D Surmatis, 111Jason Surnear, 39Bradford C Surner, 74

Eva Surmacz Phones & Addresses

  • 706 S 2Nd St UNIT 8, Philadelphia, PA 19147
  • 715 Philip St, Philadelphia, PA 19147
  • Phila, PA
  • 706 S Second St UNIT 8, Philadelphia, PA 19147

Resumes

Resumes

Eva Surmacz Photo 1

Scientific Advisor, Pre-Clinical Oncology

View page
Location:
Philadelphia, PA
Industry:
Biotechnology
Work:
Arrevus
Scientific Advisor, Pre-Clinical Oncology
Temple University 2005 - 2018
Professor In Biology, Director, Obesity and Cancer Program at Shro Institute
Temple University Jan 2015 - Dec 2017
Academic Director, Professional Science Masters Program In Bioinnovation
Allysta Jan 2015 - Dec 2017
Senior Scientific Advisor, Scientific Advisory Board Member
Peptherx Feb 2011 - Sep 2011
Co-Founder and Vice President, Research
Skills:
Molecular Biology
Cancer
Life Sciences
Cell Biology
Clinical Development
Research
Biotechnology
Biochemistry
Clinical Trials
Translational Research
Immunology
Science
Cell Culture
Lifesciences
Leadership
Hplc
Pcr
Western Blotting
Oncology
Interests:
Science and Technology
Languages:
English
Polish
French
Italian
Russian
Latin
Certifications:
Hipaa
Eva Surmacz Photo 2

Propriã Taire

View page
Location:
Philadelphia, PA
Work:
Biotech
Propriã Taire
Eva Surmacz Photo 3

Chef D'entreprise, Biotech

View page
Position:
Propriétaire at biotech
Location:
Région de Greater Philadelphie , États-Unis
Industry:
Biotechnology
Work:
biotech Occupe actuellement ce poste
Propriétaire

Publications

Us Patents

Leptin Agonist And Methods Of Use

View page
US Patent:
20110015124, Jan 20, 2011
Filed:
Feb 27, 2009
Appl. No.:
12/919408
Inventors:
Eva Surmacz - Philadelphia PA, US
Laszlo Otvos, JR. - Audubon PA, US
Assignee:
Temple University of the Commomwealth System of Higher Eduacation - Philadelphia PA
International Classification:
A61K 38/08
C07K 7/06
C07K 7/08
A61K 38/10
A61P 3/04
A61P 3/00
A61P 15/00
US Classification:
514 48, 530328, 530327, 514 58
Abstract:
Peptides are provided having leptin receptor agonist activity. The peptides are useful for treating obesity, insulin resistance, lipodystrophy and hypothalamic amenorrhea, anorexia-related infertility, among other diseases and conditions related to leptin deficiency and/or leptin resistance.

Leptin Antagonist And Methods Of Use

View page
US Patent:
20120142585, Jun 7, 2012
Filed:
Mar 30, 2010
Appl. No.:
13/262186
Inventors:
Laszlo Otvos - Audubon PA, US
Eva Surmacz - Philadelphia PA, US
Assignee:
TEMPLE UNIVERSITY-OF THE C0MMONWEALTH SYSTEM OF HIGHER EDUCATION - Philadelphia PA
International Classification:
A61K 38/03
C07K 19/00
A61P 35/00
A61P 1/00
A61P 19/10
A61P 19/02
G01N 33/566
A61P 29/00
C07K 4/00
A61P 3/00
US Classification:
514 48, 530300, 514 193, 514 194, 514 195, 514 169, 514 166, 435 723, 514 168, 514 11
Abstract:
This invention provides compounds that are true antagonists of the leptin receptor, in the presence and the absence of native leptin or another leptin receptor binder. These compounds may be used to inhibit leptin receptor activity, promote growth arrest or death of leptin receptor-positive cancer cells, or monitor or detect a leptin receptor-positive cell, in vitro or in vivo. These compounds may also be used to treat a weight-loss nutritional disorder, osteoporosis, rheumatoid arthritis, osteoarthritis, or inflammatory bowel disease. Also included in the invention are methods for detecting leptin receptor-positive cells, for arresting cell growth or killing cancer cells in vivo, for monitoring or detecting a leptin receptor-positive cell in vitro or in vivo, for treating a weight-loss nutritional disorder, for treating osteoporosis, for treating rheumatoid arthritis, for treating osteoarthritis, or for treating inflammatory bowel disease.

Adiponectin Receptor Agonists And Methods Of Use

View page
US Patent:
20140057833, Feb 27, 2014
Filed:
Apr 11, 2012
Appl. No.:
14/110813
Inventors:
Laszlo Otvos - Audubon PA, US
Eva Surmacz - Philadelphia PA, US
Assignee:
TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION - Philadelphia PA
International Classification:
C07K 7/06
US Classification:
514 19, 514 167, 514 179, 514 193, 514 194, 514 195, 514 196, 514 208, 514 216, 530327, 530328
Abstract:
Short peptide mimetics of adiponectin suitable for development as pharmaceutical agonists in the treatment of cellular proliferative disorders such as cancer and atherosclerosis are provided.
Control profile
Eva Surmacz from Phila, PA, age ~67 Get Report